APA (7th ed.) Citation

Stohl, W., Schwarting, A., Okada, M., Scheinberg, M., Doria, A., Hammer, A. E., . . . Gordon, D. (2017). Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty‐Two–Week Randomized, Double‐Blind, Placebo‐Controlled Study. Arthritis & rheumatology (Hoboken, N.J.), 69(5), 1016-1027. https://doi.org/10.1002/art.40049

Chicago Style (17th ed.) Citation

Stohl, William, et al. "Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty‐Two–Week Randomized, Double‐Blind, Placebo‐Controlled Study." Arthritis & Rheumatology (Hoboken, N.J.) 69, no. 5 (2017): 1016-1027. https://doi.org/10.1002/art.40049.

MLA (9th ed.) Citation

Stohl, William, et al. "Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty‐Two–Week Randomized, Double‐Blind, Placebo‐Controlled Study." Arthritis & Rheumatology (Hoboken, N.J.), vol. 69, no. 5, 2017, pp. 1016-1027, https://doi.org/10.1002/art.40049.